SEC Company Response from PULSE BIOSCIENCES, INC. (PLSE) (CIK 0001625101) (PLSE) — Apr 24, 2020
PULSE BIOSCIENCES, INC. (PLSE) (CIK 0001625101)
Date: April 24, 2020 · CIK: 0001625101 · Accession: 0001140361-20-009751
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-237577
Letter
PULSE BIOSCIENCES, INC.
957 Point Eden Way
Hayward, California 94545
April 24, 2020
Via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, NE
Washington, D.C. 20549-3561
Attention:
Mr. Jeffrey Gabor
Ms. Celeste Murphy
Re:
Pulse Biosciences, Inc.
Registration Statement on Form S-3
Filed April 6, 2020
File No. 333-237577
Withdrawal of Acceleration Request
Ladies and Gentlemen:
Pulse Biosciences, Inc. (the “Company”) hereby respectfully requests withdrawal of its acceleration request filed on April 22, 2020, relating to its Registration Statement on Form S-3 (File No. 333-237577) (the “Registration Statement”). The Company is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.
If you have any questions regarding the foregoing, please contact our counsel, Andrew D. Hoffman of Wilson Sonsini Goodrich & Rosati, P.C., at (650) 849-3240 or ahoffman@wsgr.com.
Sincerely,
PULSE BIOSCIENCES, INC.
Show Raw Text
CORRESP
1
filename1.htm
PULSE BIOSCIENCES, INC.
957 Point Eden Way
Hayward, California 94545
April 24, 2020
Via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street, NE
Washington, D.C. 20549-3561
Attention:
Mr. Jeffrey Gabor
Ms. Celeste Murphy
Re:
Pulse Biosciences, Inc.
Registration Statement on Form S-3
Filed April 6, 2020
File No. 333-237577
Withdrawal of Acceleration Request
Ladies and Gentlemen:
Pulse Biosciences, Inc. (the “Company”) hereby
respectfully requests withdrawal of its acceleration request filed on April 22, 2020, relating to its Registration Statement on Form S-3 (File No. 333-237577) (the
“Registration Statement”). The Company is no longer requesting that such Registration Statement be declared effective at this time and we hereby formally withdraw our request for acceleration of the effective date.
If you have any questions regarding the foregoing, please contact our counsel, Andrew D. Hoffman of Wilson Sonsini Goodrich & Rosati, P.C., at (650) 849-3240 or ahoffman@wsgr.com.
Sincerely,
PULSE BIOSCIENCES, INC.
By:
/s/ Sandra A. Gardiner
Sandra A. Gardiner
Chief Financial Officer, Executive Vice President of Finance and Administration, Secretary and Treasurer
cc:
Andrew D. Hoffman, Esq.,
Wilson Sonsini Goodrich & Rosati, P.C.